PHARMACEUTICALS
Build Healthy Cyber Immunity
Pharmaceuticals save lives and improve patient care, but the industry faces a unique cyberthreat landscape. Protect your operations and critical proprietary data from human-based cyber risk by improving your security posture with NINJIO.

Proactive Action Is the Best Medicine
From major manufacturers to biotech startups, social engineering cyberattacks continue to be an urgent threat to the sector. Due to the sensitive data that pharmaceutical and biotech companies store, as well as their complex supply chains, organizations like yours need a robust cybersecurity awareness platform to stay proactive. Through personalized coaching, engaging training, and dynamic phishing simulations, your team can counter attacks and prevent data breaches.
NINJIO Meets Your Prescriptive Needs
Keep your entire organization safe and make behavior change easy with NINJIO’s all-in-one human risk management platform. Our personalized security coaching, engaging awareness training, and advanced simulated phishing will not only educate but also ignite cultural change in the workplace.

Report
Increase Cybersecurity Immunity
Research labs and healthcare partners continue to be targeted by cybercriminals who use AI-enhanced social engineering to steal billion-dollar IP and patient data. Discover more about rapidly increasing cyber threats and how you can use evidence-based methods to build stronger human-based cyber defense.

Frequently Asked Questions
The majority of pharmaceutical cyberattacks stem from factors such as human error and social engineering attacks. Many pharmaceutical organizations lack an enterprise-wide cybersecurity mindset, which affects their ability to identify and prevent attacks.
The pharmaceutical industry has valuable assets that include drug formulas, clinical trial data, and patient information. This large amount of sensitive information often becomes a target for cybercriminals, which leads to devastating impacts.
Data breaches are very significant in the healthcare and pharmaceutical industries, averaging at $5.1 million per incident. These attacks cause severe financial and data privacy losses, putting not only organizations at risk but patients as well.